New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
09:14 EDTDEPO
theflyonthewall.com: DepoMed may be at good entry point, says Roth Capital
After DepoMed's hot flashes trial failed, Roth Capital thinks the second attempt at the trial will be successful. The firm notes that Depomed's second trial of its PHN indication was successful after an initial failure and proved to be a good entry point in the stock. The firm reiterates a Buy rating on the shares. :theflyonthewall.com



News For DEPO From The Last 14 Days
Check below for free stories on DEPO the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 1, 2010
08:33 EDTDEPO
theflyonthewall.com: DepoMed announces allowance of U.S. patent covering gastric dosage forms
Depomed announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a U.S. patent application directed to pharmaceutical dosage forms that deliver the compound gabapentin via Depomed’s proprietary Acuform gastric retentive drug delivery technology. :theflyonthewall.com